attenuated Leishmania major vaccine (Gennova Biopharmaceuticals/Ohio State University/McGill University)

N/A

Report date: 2025/03/14 16:32:48

Base Information

Drug Nameattenuated Leishmania major vaccine (Gennova Biopharmaceuticals/Ohio State University/McGill University)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLeishmaniasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A